| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.51B | $1.46B | $1.38B |
| YoY Revenue Growth % | +3.3% | +5.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.53B | $3.67B | $2.95B |
| Operating Margin % | 300.6% | 251.8% | 213.8% |
| Net Income (GAAP) | $3.84B | $3.11B | $2.50B |
| EBITDA (Normalized) | $4.66B | $3.79B | $3.00B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.92B | $5.91B | $4.22B |
| Capital Expenditures (CapEx) | $169.0M | $145.0M | $62.2M |
| Free Cash Flow (FCF) | $5.75B | $5.76B | $4.16B |
| FCF Margin % | 382.0% | 395.3% | 300.9% |
| Return on Invested Capital (ROIC %) | 25.8% | 24.3% | 19.9% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $4.37B | $4.37B | $4.54B |
| Total Stockholders' Equity | $18.98B | $16.45B | $9.32B |